Latest News Feed

Press Release Jun 10, 2024
SOHM, Inc. Announces its ABBIE Genome Editing Technology Successfully Engineered a T-cell immunotherapy from a Healthy Human Donor
Press Release Aug 8, 2023
SOHM, Inc. Announce the Appointment of Dr. David Aguilar, Ph.D. as a Chief Operating Officer with the Company with Immediate Effect
Press Release Aug 1, 2023
SOHM Inc. Signs LOI to Acquire Stem Cell Disruptive Technology and Patents
Press Release Jul 25, 2023
SOHM Inc. Announces the Closure of Finances-Funding for its Various Projects
Press Release Apr 26, 2023
SOHM Inc. Signed an Exclusive Distribution Agreement with India-based Stallion Laboratories Pvt. Ltd. for Levetiracetam for the Treatment of Epilepsy
Press Release Mar 20, 2023
SOHM, Inc. Introduces and Received Topical Skincare Line of Products Orders in Its Label
Press Release Oct 18, 2022
SOHM, Inc. Signs MOU with London/Asia-Based Fund to Infuse Funds for Various Projects
Press Release Mar 2, 2022
SOHM, Inc. Expands Advisory Board with Appointment of Dr. David Aguilar Ph.D., as its Expert Medical Advisor.
Press Release Feb 23, 2022
SOHM, Inc. Announces the Appointment of Wm. Dewey Rushing, former US FDA Investigator to its Advisory Board
Press Release Nov 30, 2021
SOHM, Inc., Collaborates for Commercial Manufacturing of Brainwise(R), a Patented Omega 3 Formula for Global Distribution
Press Release Nov 15, 2021
SOHM, Inc. Signs Industry Expert Sivana Group as Strategic Consultant for Rebranding and Global Expansion
Press Release Nov 11, 2021
SOHM, Inc., Announces Important Details of Its California Pharmaceutical Company Acquisition Expanding Manufacturing into the US Market
Press Release Sep 30, 2021
SOHM, Inc., Signed a Definitive Agreement for Acquisition of Californian Pharmaceutical Company
Press Release Sep 29, 2021
SOHM Receives Repeat New Order From Private Label Customer